The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Dec 31, 2025
GROW Funds LLC ended 2025 with strong performance, with managed portfolios delivering net returns between +7% and +23%, and its accredited-only hedge fund up approximately 175% net of fees. The firm highlighted its active management strategy, which involved taking capital gains on fully valued names and rotating capital into an overweight position in healthcare (offering offensive pipeline catalysts and defensive insulation). Key stock discussions focused on Mama's Creations (MAMA) and Axsome Therapeutics (AXSM) as core contributors, while defending MDxHealth (MDXH) as deeply undervalued. On macro themes, the manager notes that Fed rate cuts favor small-cap equities, remains highly skeptical of 'Magnificent 7' valuations and massive AI Capex spend reminiscent of the dot-com bubble, and asserts that active stock picking is uniquely positioned to outperform passive indices.
Maximizing returns through high-conviction, active stock selection in companies delivering robust revenue and earnings growth, while utilizing sector rotation (such as shifting to healthcare) and relative valuation discrepancies (small/mid-cap over concentrated mega-cap indexes) to navigate market volatility.
The manager sees tremendous investment opportunities in the market, driven by stark valuation discrepancies and a favorable interest rate-cutting cycle. They believe the current environment strongly favors active management and careful stock selection over passive index tracking, focusing on firms with new products, large markets, and robust margins.
High Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with GROW Funds or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.